The relationship of abnormal circulating insulin levels to atherosclerosis

Atherosclerosis

Volumn 27, Issue 1, 1977, Pages 1-13

  Stout, Robert W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Artery; Atherosclerosis; Diabetes; Glucose; Insulin; Lipids; Obesity; Smooth muscle cell

Indexed keywords

INSULIN;

ATHEROSCLEROSIS;

BIOLOGY; CARBOHYDRATE METABOLIC EFFECTS; CARDIOVASCULAR EFFECTS; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CYTOLOGIC EFFECTS; DIABETES MELLITUS; DISEASES; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; GLUCOSE METABOLISM EFFECTS; GLUCOSE TOLERANCE TEST; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; LIPID METABOLIC EFFECTS; LIPIDS; LITERATURE REVIEW; METABOLIC EFFECTS; OBESITY; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY;

ANIMAL; AORTA; ARTERIOSCLEROSIS; CONTRACEPTIVES, ORAL; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIET, ATHEROGENIC; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INSULIN; LIPID MOBILIZATION; LIPIDS; MALE; MUSCLE, SMOOTH; OBESITY; RISK; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES; UREMIA;

EID: 0017347139     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(77)90018-1     Document Type: Review

References (103)

1. Atherosclerosis and disorders of lipid metabolism in diabetes
2. Morbidity and mortality in diabetics in the Framingham population — Sixteen year follow-up study
3. The relationship of cardiovascular disease to hyperglycemia
4. Blood sugar and arterial disease
5. Some uses of prospective observations in the Tecumseh community health study
6. Macroangiopathy — Its prevelance in asymptomatic diabetes
7. Atherosclerosis in persons with hypertension and diabetes mellitus
8. Glucose tolerance in ischaemic cardiovascular disease
9. Hyperglycaemia — A risk factor in coronary heart disease
10. A study of the effects of hypoglycemic agents on the vascular complications of patients with adult onset diabetes
11. Human insulin secretion — An integrated approach
12. The significance of basal insulin levels in evaluation of the insulin response to glucose in diabetic and non-diabetic subjects
13. Obesity, parity and diabetes
14. Insulin excess as the initial lesion in diabetes
15. Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes?
16. Insulin responses to oral carbohydrate in true pre-diabetics and matched controls
17. The pancreas
18. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion
19. The liver in glucose homeostasis in normal man and in diabetes
20. Determination of total serum insulin (IRI) in insulin-treated diabetic patients
21. Serum (IRI) in insulin-treated diabetics during a 24-hour period
22. A simple method for the determination of serum free insulin-treated patients
23. Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects
24. Atherosclerosis in diabetes mellitus
25. Plasma insulin concentrations after myocardial infarction
26. Plasma insulin in coronary heart disease
27. Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients in coronary heart disease
28. Glucose tolerance, plasma lipids and serum insulin in patients with ischemic heart disease
29. The pattern of plasma insulin response to glucose in patients with a previous myocardial infarction—The respective effects of age and disease
30. Ischemic heart disease—Insulin, carbohydrate and lipid interrelationships
31. The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease
32. Serum-insulin in essential hypertension and peripheral vascular disease
33. Covert diabetes mellitus in ischemic heart and cerebrovascular disease
34. Ischaemic heart disease and associated risk factors in 40-year old men in Edinburgh and Stockholm
35. Metabolic responses to oral glucose in healthy South African white, Indian, and African subjects
36. Coronary-prone individuals (type A behavior pattern) — Some biochemical characteristics
37. Insulin and the heart
38. Insulin sensitivity and vascular disease in maturity onset diabetes
39. Carbohydrate metabolism in myocardial infarction—Behavior of blood glucose and free fatty acids after glucose loading
40. Ischaemic heart disease in relation to fasting values of plasma triglyceride and cholesterol
41. Hyperlipidemia in coronary heart disease—Lipid levels in 500 survivors of myocardial infarction
42. The significance of blood lipid alterations in diabetes mellitus
43. Hypertriglyceridemia and glucose intolerance in man
44. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia
45. Reappraisal of the role of insulin in hypertriglyceridemia
46. Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus
47. The immediate effects of insulin and fructose on the metabolism of the perfused liver — Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism
48. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects
49. Hormonal control of adipose tissue metabolism, with special reference to the effects of insulin
50. Relationship between serum cholesterol and body fatness — An epidemiological study
51. The relation of adiposity to blood pressure and development of hypertension—The Framingham study
52. Accelerated atherosclerosis in prolonged maintenance hemodialysis
53. Disorders of carbohydrate and lipid metabolism in uremia
54. Uremic lipemia
55. Oral contraceptives and death from myocardial infarction
56. Contraceptive steroids — Modifications of carbohydrate and lipid metabolism
57. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives
58. The effect of alloxan diabetes on experimental atherosclerosis in the rabbit Part 1 (The inhibition of experimental atherosclerosis in alloxan diabetes) Part 2 (The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis)
59. The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit
60. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit Part 4 (The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit)
61. The mechanism of alloxan protection in experimental atherosclerosis
62. Studies on diabetic rats — The production of cardiovascular and renal disease in diabetic rats
63. The effect of insulin deficiency, hypothyroidism, and hypertension on atherosclerosis in the squirrel monkey
64. Dietary atherogenesis in alloxan diabetes
65. The relationship of serum lipoproteins to atherosclerosis in the cholesterol-fed alloxanized rabbit
66. The effect of an atherogenic diet on normal and alloxan-diabetic rats
67. Evaluation of the relative pathogenic roles of diabetes and serum cholesterol levels in the development of cardiovascular lesions in rats
68. Failure of insulin therapy to prevent cardiovascular lesions in diabetic rats fed an atherogenic diet
69. Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs
70. Effect of insulin in the induction and regression of atherosclerosis in the chick
71. Laboratory animals with spontaneous diabetes and/or obesity — Suggested suitability for the study of spontaneous atherosclerosis
72. The relationship of arterial disease and glucagon metabolism in insulin-treated chickens
73. Lipid-carbohydrate Interrelationships in Atherosclerosis
74. Development of vascular lesions in insulin-treated animals fed a normal diet
75. The effect of diabetes and insulin on biochemical reactions of the arterial wall
76. Determinants of human adipose tissue lipoprotein lipase—Effect of diabetes and obesity on basal and diet-induced activity
77. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins
78. Very low density lipoprotein “remnant” particles: uptake by aortic smooth muscle cells in culture
79. The presence of a hormone-sensitive cyclase system in the rat aorta and its relation to lipolysis
80. Effects of diabetes on cholesterol and fatty acid synthesis in the rat aorta
81. Metabolism of glycose-U-C14 in rat aorta in vitro
82. Effects of insulin and alloxan diabetes on glucose metabolism in rabbit aortic tissue
83. Morphology and metabolism of an aortic intima-media preparation in which an intact endothelium is preserved
84. Aortic glucose metabolism in the diabetic chinese hamster
85. Glucose lipogenesis in rabbit aorta in relation to age, degree of atherosclerosis, and the presence of insulin
86. Effects of insulin on glucose metabolism in vascular and intestinal smooth muscle
87. Insulin stimulated lipogenesis in arterial tissue in relation to diabetes and atheroma
88. The effect of insulin on the incorporation of D-glucose-U-14C into the lipids of the rat aorta in vivo
89. The effect of insulin on the incorporation of (1–14C) sodium acetate into the lipids of the rat aorta
90. Uptake of labelled cholesterol from plasma by aortic intima-media in control and insulin-injected rabbits
91. Insulin stimulation of cholesterol synthesis by arterial tissue
92. Arterial lipid metabolism in relation to blood glucose and plasma insulin in rats with streptozotocin-induced diabetes
93. The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells
94. Stimulation by insulin of rat liver β-hydroxy-β-methylglutaryl coenzyme A reductase and cholesterol synthesising activities
95. Effect of insulin on sterol and fatty acid synthesis and hydroxymethylglutaryl Co A reductase activity in mammalian cells grown in culture
96. Fat synthesis in cultures of cells of arterial intima
97. Atherosclerosis and the smooth muscle cell
98. Evidence for a monoclonal origin of human atherosclerotic plaques
99. The smooth muscle cell, Part 2 (Growth of smooth muscle in culture and formation of elastic fibres)
100. The effect of insulin on the proliferation of cultured primate arterial smooth muscle cells
101. Lipoprotein receptors, cholesterol metabolism, and atherosclerosis
102. Insulin and atheroma